Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03660800 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects
A Phase 1 study, sponsored by OPKO Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
NCT03660800 is a Phase 1 study that has completed, run by OPKO Health. The registered enrollment target is 67 participants.
The verdict
NCT03660800, a Phase 1 study, has completed, sponsored by OPKO Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
Study Summary
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and non-Japanese Healthy Subjects
Interventions
- DRUG CTAP101 Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2018-08-20 |
| Est. Completion | 2019-01-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03660800
The ClinicalTrials.gov registry entry for NCT03660800 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OPKO Health, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CTAP101 Capsules is the first listed.
NCT03660800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03660800 about?
NCT03660800 is a clinical study titled "Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects". Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and non-Japanese Healthy Subjects
What is the current status of trial NCT03660800?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2018-08-20. Estimated completion is 2019-01-22.
What interventions are being tested in trial NCT03660800?
The interventions under investigation include: CTAP101 Capsules (DRUG).
Who is sponsoring clinical trial NCT03660800?
This trial is sponsored by OPKO Health, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.